From microfluidics to metastasis
New platform enables longitudinal studies of circulating tumor cells in mouse models of cancer.
Search Stories
Progress against pancreatic cancer
Lustgarten Foundation names MIT laboratory to improve understanding and treatment of a deadly disease
Exploring cancer metabolism
Matthew Vander Heiden seeks new cancer treatments that exploit tumor cells’ abnormal metabolism.
Restricting a key cellular nutrient could slow tumor growth
Researchers identify the amino acid aspartate as a metabolic limitation in certain cancers.
Biologists discover how pancreatic tumors lead to weight loss
Shortfall of digestive enzymes can lead to tissue breakdown in early stages of pancreatic cancer.
Fine-tuning cancer medicine
New cancer research initiative eyes individualized treatment for patients.
Over the river and do some good
The Bridge Project collaboration accelerates new, highly original, and powerful approaches to defeating cancer.
New target for treating “undruggable” lung cancer
Drug already in clinical trials may be effective on some aggressive adenocarcinomas.
Gene Brown, professor emeritus of biology, dies at 91
A pioneer in the field of intermediary metabolism and former dean of the School of Science, Brown’s deepest passion was teaching.
School of Science professors granted tenure
Seven award-winning faculty members represent the departments of Physics, Chemistry, and Biology.
Four MIT professors named inaugural Faculty Scholars
New program from the Howard Hughes Medical Institute, Simons Foundation, and Bill and Melinda Gates Foundation supports early-career scientists.
How cancer cells fuel their growth
Scientists surprised to find amino acids, not sugar, supply most building blocks for tumor cells.
Identifying a key growth factor in cell proliferation
Researchers discover that aspartate is a limiter of cell proliferation.
Biologists identify brain tumor weakness
Discovery could offer a new target for treatment of glioblastoma.
Cerebral curiosity
Graduate student Steven Keating takes a problem-solving approach to his brain cancer.